Plain-English translation of NCT03054584 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at UC Davis want to understand what genetic changes cause common skin moles (melanocytic nevi) to form. By studying DNA from mole tissue and normal skin, they hope to learn more about how these benign growths develop and what makes them different from normal skin cells.
Moles are very common, but scientists still don't fully understand the genetic basis for why they appear. Learning more about the genes involved could help doctors better understand moles and potentially improve how they're diagnosed and monitored in the future.
You likely qualify if…
You likely don't qualify if…
You would have a small skin biopsy taken from one of your moles (either a shave or punch biopsy — a quick, minimally invasive procedure). You would also provide a blood sample. The skin tissue will be examined under a microscope and analyzed for genetic information, while your blood serves as a normal control sample to help researchers identify the specific genetic changes in your moles.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
United States
Enrollment target
~50 participants
Started
June 2017
Primary completion
June 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in September 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Maija Kiuru, MD
University of California, Davis
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.